PIPELINE

Clinical Candidate

Indication

Research

Preclinical

Clinical Phase

AL-1

Polycystic kidney disease (PKD)

AL-2

Fabry disease

AL-3

Undisclosed program

© Copyright AceLink Therapeutics. All rights reserved